"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...

Speaking to the press on the sidelines of the annual Semicon India Summit 2026 in the capital, Vaishnaw said the growth of the ecosystem in...

India's electronics minister has asserted the country's competitive edge in the global semiconductor market. Currently, five chip packaging...

India’s semiconductor industry has become globally competitive in quality and cost, with products from five operational facilities meeting ...

Maharashtra's Chief Minister Devendra Fadnavis invited Belgian companies to explore investment opportunities within the state, positioning ...

CEPI first partnered with IVI and Bharat Biotech in June 2020, providing up to USD 14.1 million for vaccine manufacturing and clinical deve...

Investing in upgrading a BSL-3 lab to make it fit for production will have uses beyond the manufacture of Covaxin. Going beyond the financi...

The indigenous, inactivated vaccine is being developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) bio-containment faci...

The platform will facilitate the expansion of BIRAC’s empowering policies, mentoring, and market access to biotech innovators across India ...

In 2012, DuBiotech witnessed exceptional growth, issuing 40 commercial licences in comparison to 21 in 2011.

ABLE and BIRAC have signed an agreement to facilitate technical knowledge and exchange information on the biotech industry.

India is losing competitive advantage due to hesitancy to widely adopted "risk-free" biotech crop technique.

Biocon will invest $161 million in a facility in Malaysia, joining a number of Indian companies that have chosen to establish facilities in...

These initiatives are happening at a time when pharmaceutical companies, too, seem unable to find takers for their molecules in a challengi...

In a bid to boost discovery and innovation in the biotech sector, government today approved a public private partnership programme earmarki...

Multi-billion-dollar pharma ingredient and chemicals major DSM is in talks with Indian biotech companies to outlicense its exclusive techno...

The Centre will announce a comprehensive National Biotechnology Policy in the next six to seven months, Union Biotechnology Secretary MK Bh...